Gsk 2025 Full Year

Gsk 2025 Full Year. The news comes on the heels of better. We are now planning for at least 12 major launches from 2025, with new vaccines and specialty medicines for infectious diseases, hiv, respiratory, and oncology.


Gsk 2025 Full Year

Gsk plc raised its guidance for the year after a strong start to 2023 as it prepares to begin selling one of the first vaccines to prevent a common respiratory virus. Glaxosmithkline aims to earn 33 billion pounds, or roughly $46 billion, in annual sales in 2031, betting that new experimental drugs for infectious disease, cancer.

Gsk 2025 Full Year Images References :